Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy

Authors

Institutions

Publication Details

Journal
BMC Gastroenterology
Published
2025-08-20
DOI
https://doi.org/10.1186/s12876-025-04208-z
Citations
1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy

Zhi-guo Ai, Xu Zhang
1 citations
BMC Gastroenterology
Hepatocellular Carcinoma Treatment and Prognosis
1.32
article

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy

Zhi-guo Ai, Xu Zhang
article en
1 citations

Abstract

No abstract available for this paper.
BMC GastroenterologyVol. 25(1)
Huizhou Central People's Hospital (CN)
Openalex Percentile: Top 17%
Hepatocellular Carcinoma Treatment and Prognosis
1.32
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy — Zhi-guo Ai, Xu Zhang · BMC Gastroenterology (2025) | TGRS Research Map | TGRS